COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect
NanoViricides, Inc. reports positive results of broad-spectrum antiviral drug NV-387 in animal models, showing sustained antiviral effect with extended flat blood concentration profile upon oral administration -
COMMUNIQUÉ DE PRESSE
Fiches relatives aux Caisses locales
-
-
-
COMMUNIQUÉ DE PRESSE
SolarWorld AG (WKN: A1YCN1 / WKN: A1YDDX) – Information on the status of the insolvency proceedings of SolarWorld Aktiengesellschaft
Update on the insolvency proceedings of SolarWorld Aktiengesellschaft, including distribution of liquidation proceeds and claims of secured creditors -
COMMUNIQUÉ DE PRESSE
CEMP Rapport annuel exercice 2023
-
-
COMMUNIQUÉ DE PRESSE
SolarWorld AG (WKN: A1YCN1 / WKN: A1YDDX) - Interim distribution to the bondholders - Submission of the necessary information
SolarWorld AG announces interim distribution to bondholders from insolvency proceedings, requests bondholder information for settlement transfer. Contact One Square Advisors for details
